Stifel Maintains Buy on DocGo, Lowers Price Target to $2.5

Benzinga Newsdesk www.benzinga.com Negative 77.5%

Neg 77.5% Neu 0% Pos 0%

Stifel analyst David Grossman maintains DocGo (NASDAQ:DCGO) with a Buy and lowers the price target from $4 to $2.5.

Comments

No comments yet. Be the first!